147 related articles for article (PubMed ID: 26315676)
1. The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model.
Pinto LC; Soares BM; Pinheiro Jde J; Riggins GJ; Assumpção PP; Burbano RM; Montenegro RC
Toxicol In Vitro; 2015 Dec; 29(8):2038-44. PubMed ID: 26315676
[TBL] [Abstract][Full Text] [Related]
2. Mebendazole induces apoptosis via C-MYC inactivation in malignant ascites cell line (AGP01).
Pinto LC; Mesquita FP; Soares BM; da Silva EL; Puty B; de Oliveira EHC; Burbano RR; Montenegro RC
Toxicol In Vitro; 2019 Oct; 60():305-312. PubMed ID: 31207347
[TBL] [Abstract][Full Text] [Related]
3. Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis.
Celestino Pinto L; de Fátima Aquino Moreira-Nunes C; Soares BM; Burbano RMR; de Lemos JAR; Montenegro RC
Toxicol In Vitro; 2017 Sep; 43():87-91. PubMed ID: 28606429
[TBL] [Abstract][Full Text] [Related]
4. EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH.
Sawanyawisuth K; Williamson T; Wongkham S; Riggins GJ
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1264-70. PubMed ID: 26466412
[TBL] [Abstract][Full Text] [Related]
5. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
[TBL] [Abstract][Full Text] [Related]
6. Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.
Younis NS; Ghanim AMH; Saber S
Sci Rep; 2019 Dec; 9(1):19095. PubMed ID: 31836811
[TBL] [Abstract][Full Text] [Related]
7. Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid Leukemia.
Freisleben F; Modemann F; Muschhammer J; Stamm H; Brauneck F; Krispien A; Bokemeyer C; Kirschner KN; Wellbrock J; Fiedler W
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639011
[TBL] [Abstract][Full Text] [Related]
8. Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
Rodrigues AJ; Chernikova SB; Wang Y; Trinh TTH; Solow-Cordero DE; Alexandrova L; Casey KM; Alli E; Aggarwal A; Quill T; Koegel AK; Feldman BJ; Ford JM; Hayden-Gephart M
J Neurooncol; 2024 May; 168(1):125-138. PubMed ID: 38563850
[TBL] [Abstract][Full Text] [Related]
9. Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway.
Limbu KR; Chhetri RB; Oh YS; Baek DJ; Park EY
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500220
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning.
Aliabadi A; Haghshenas MR; Kiani R; Koohi-Hosseinabadi O; Purkhosrow A; Pirsalami F; Panjehshahin MR; Erfani N
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2379-2388. PubMed ID: 37837472
[TBL] [Abstract][Full Text] [Related]
11. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.
Wang X; Lou K; Song X; Ma H; Zhou X; Xu H; Wang W
Toxicol Appl Pharmacol; 2020 Jun; 396():115001. PubMed ID: 32277947
[TBL] [Abstract][Full Text] [Related]
12. Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death.
da Silva EL; Mesquita FP; Aragão DR; de Sousa Portilho AJ; Marinho AD; de Oliveira LLB; Lima LB; de Moraes MEA; Souza PFN; Montenegro RC
Toxicol Appl Pharmacol; 2023 Sep; 475():116630. PubMed ID: 37473966
[TBL] [Abstract][Full Text] [Related]
13. XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts.
Doudican NA; Byron SA; Pollock PM; Orlow SJ
Anticancer Drugs; 2013 Feb; 24(2):181-8. PubMed ID: 23059386
[TBL] [Abstract][Full Text] [Related]
14. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer.
Nygren P; Fryknäs M; Agerup B; Larsson R
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2133-40. PubMed ID: 24135855
[TBL] [Abstract][Full Text] [Related]
15. Intestinal tubulin as possible target for the chemotherapeutic action of mebendazole in parasitic nematodes.
Köhler P; Bachmann R
Mol Biochem Parasitol; 1981 Dec; 4(5-6):325-36. PubMed ID: 7335116
[TBL] [Abstract][Full Text] [Related]
16. Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness.
Joe NS; Godet I; Milki N; Ain NUI; Oza HH; Riggins GJ; Gilkes DM
Breast Cancer Res; 2022 Dec; 24(1):98. PubMed ID: 36578038
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells.
Liu HK; Wang Q; Li Y; Sun WG; Liu JR; Yang YM; Xu WL; Sun XR; Chen BQ
J Nutr Biochem; 2010 Mar; 21(3):206-13. PubMed ID: 19195866
[TBL] [Abstract][Full Text] [Related]
18. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.
Ho CC; Lai KC; Hsu SC; Kuo CL; Ma CY; Lin ML; Yang JS; Chung JG
Hum Exp Toxicol; 2011 Apr; 30(4):296-306. PubMed ID: 20498032
[TBL] [Abstract][Full Text] [Related]
19. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells.
Auyeung KK; Woo PK; Law PC; Ko JK
J Ethnopharmacol; 2012 Jun; 141(2):635-41. PubMed ID: 21864667
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose.
de la Torre-Iglesias PM; García-Rodriguez JJ; Torrado G; Torrado S; Torrado-Santiago S; Bolás-Fernández F
Drug Des Devel Ther; 2014; 8():1467-79. PubMed ID: 25258515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
